Interestingly, the addition of siRNA against STAT1 increases the levels of these proangiogenic molecules, indicating that IL-27 inhibits the production of angiogenic factors through a STAT1 pathway and VEGF production in human NSCLC [93,94] (Figure 3). Here, STAT1 is linked to non-small cell lung carcinoma.